Mechanistic modeling of metastatic relapse in early breast cancer to investigate the biological impact of prognostic biomarkers - Inria - Institut national de recherche en sciences et technologies du numérique Accéder directement au contenu
Article Dans Une Revue Computer Methods and Programs in Biomedicine Année : 2023

Mechanistic modeling of metastatic relapse in early breast cancer to investigate the biological impact of prognostic biomarkers

Résumé

Estimating the risk of metastatic relapse is a major challenge to decide adjuvant treatment options in early-stage breast cancer (eBC). To date, distant metastasis-free survival (DMFS) analysis mainly relies on classical, agnostic, statistical models (e.g., Cox regression). Instead, we propose here to derive mechanistic models of DMFS.
Fichier principal
Vignette du fichier
Mechanistic modeling of metastatic relapse - final version.pdf (608.78 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Licence : CC BY SA - Paternité - Partage selon les Conditions Initiales

Dates et versions

hal-04008520 , version 1 (09-01-2024)

Identifiants

Citer

Célestin Bigarré, François Bertucci, Pascal Finetti, Gaëtan Macgrogan, Xavier Muracciole, et al.. Mechanistic modeling of metastatic relapse in early breast cancer to investigate the biological impact of prognostic biomarkers. Computer Methods and Programs in Biomedicine, 2023, 231, pp.107401. ⟨10.1016/j.cmpb.2023.107401⟩. ⟨hal-04008520⟩
62 Consultations
6 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More